224
Participants
Start Date
September 30, 2009
Primary Completion Date
June 30, 2010
Study Completion Date
September 30, 2010
Tapentadol
"Tapentadol Prolonged Release (PR) Titration and Optimal Dose Period: Starting at 50 mg Tapentadol PR twice daily, adjusting at 50 mg PR steps (upwards or downwards) as necessary to achieve a balance between pain relief and a satisfactory level of tolerability. Participants were not permitted to exceed 500 mg of Tapentadol per day.~Maintenance Period: Participants continuing on the dose established in the previous period."
Site 1, Belfort
Site 4, Marseille
Site 2, Murs Erigné
Site 3, Nantes
Site 5, Berlin
Site 2, Köln Dünnwald
Site 4, Leipzig
Site 6, Leipzig
Site 1, Marl
Site 3, Meine
Site 8, Rudolstadt
Site 4, Lodz
Site 2, Warsaw
Site 2, A Coruña
Site 7, A Coruña
Site 6, Lugo
Site 3, Madrid
Site 1, Torrelavega
Site 3, London
Site 9, London
Site 06, Manchester
Site 08, Portsmouth
Site 1, Solihull
Site 4, Swansea
Lead Sponsor
Grünenthal GmbH
INDUSTRY